Trials / Completed
CompletedNCT05113472
Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers
Adverse Reactions Following COVID-19 Vaccination: an Ecuadorian Experience
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,291 (actual)
- Sponsor
- Respiralab · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
Limited large-scale studies have been conducted to investigate the adverse effects of COVID-19 vaccine in Latin America, particularly among the healthcare worker (HCW) population in Ecuador. The objective of this study was to assess a cohort of Ecuadorian healthcare workers for adverse reactions following vaccination with the Pfizer-BioNTech vaccine.
Detailed description
The COVID-19 pandemic bears a burden on medical care and economies worldwide, however immunization at the population level provides a way for to reduce future morbidity and mortality. Vaccine hesitancy and reluctance in getting the COVID-19 vaccine and apprehensions about them have been present along the course of vaccination programs and mass immunizations across the world. Factors such as the quick, large-scale production of vaccines, lack of information, and uncertainty about adverse reactions in the public's eye as well about myths spreading through media channels have given rise to suspicion and fear in the Latin American population. Limited large-scale studies have been conducted to investigate the adverse effects of COVID-19 vaccine in Latin America, particularly among the healthcare worker (HCW) population in Ecuador. The objective of this study was to assess a cohort of Ecuadorian healthcare workers for adverse reactions following vaccination with the Pfizer-BioNTech vaccine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Pfizer-BioNTech COVID-19 vaccine | Patients who were administered any dose of the Pfizer-BioNTech COVID-19 vaccine. |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2021-05-31
- Completion
- 2021-05-31
- First posted
- 2021-11-09
- Last updated
- 2021-11-09
Locations
1 site across 1 country: Ecuador
Source: ClinicalTrials.gov record NCT05113472. Inclusion in this directory is not an endorsement.